Detalles de la búsqueda
1.
To compare the efficacy and incidence of severe hematological adverse events of flumatinib and imatinib in patients newly diagnosed with chronic phase chronic myeloid leukemia / 中华血液学杂志
Chinese Journal of Hematology
; (12): 728-736, 2023.
Artículo
en Zh
| WPRIM | ID: wpr-1012221
2.
Effect of 1q21 amplification on bortezomib therapeutic response and prognosis of newly diagnosed multiple myeloma patients / 中华血液学杂志
Chinese Journal of Hematology
; (12): 408-413, 2018.
Artículo
en Zh
| WPRIM | ID: wpr-1011774
Resultados
1 -
2
de 2
1
Próxima >
>>